DPYSL2 and urinary bladder cancer: In this study, we demonstrated that in the TCGA dataset, high DPYSL2 expression in bladder cancer tissue significantly correlated with decreased overall survival and recurrence-free survival, along with increased T stage, N stage, clinical stage, and tumor recurrence and progression in patients.